Principia Biopharma's activity chart (see below) currently has 30 price targets and 25 ratings on display.
Analysts' price targets on this stock were met 92.14% of the time, taking 114 days on average.
Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 20-Aug-2020. First documented stock forecast 09-Oct-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Apr-2019
$76
6 years 3 months 2 days ago
(20-Aug-2020)
5/5 (100%)
$22.11 (41.03%)
110
Buy Since 09-Oct-2018
$100
$112
6 years 3 months 4 days ago
(18-Aug-2020)
3/4 (75%)
$0.39 (0.39%)
137
Buy Since 09-Oct-2018
$100
$78
6 years 3 months 4 days ago
(18-Aug-2020)
3/3 (100%)
$0.39 (0.39%)
174
Buy Since 01-Jul-2019
$108
6 years 3 months 5 days ago
(17-Aug-2020)
6/7 (85.71%)
$16.11 (17.53%)
72
Buy Since 09-Oct-2018
$68
$33
6 years 9 months 30 days ago
(23-Jan-2020)
2/2 (100%)
$7.8 (12.96%)
77
What is PRNB (Principia Biopharma) average time for price targets to be met?
Which analyst most recently updated their price target on PRNB (Principia Biopharma)?
Which analyst has the lowest performance score on PRNB (Principia Biopharma) with a proven track record?
Which analyst has the most public recommendations on PRNB (Principia Biopharma)?
Which analyst is the currently most bullish on PRNB (Principia Biopharma)?
Which analyst is the currently most reserved on PRNB (Principia Biopharma)?